ExoCoBio pulls in $9.3m

South Korea-based ExoCoBio Inc, a exosome regenerative aesthetics company, has raised $9.3 million in funding.

27 August 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles